Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications
- PMID: 28643475
- DOI: 10.1002/jbm.a.36141
Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications
Abstract
Nanotechnology has emerged strongly as a viable option to overcome the challenge of early diagnosis and effective drug delivery, for cancer treatment. Emerging research articles have expounded the advantages of using a specific type of nanomaterial-based system called as "nanocarriers," for anti-cancer therapy. The nanocarrier system is used as a transport unit for targeted drug delivery of the therapeutic drug moiety. In order for the nanocarriers to be effective for anticancer therapy, their physicochemical parameter needs to be tuned so that bio-functionalisation can be achieved to (1) allow drugs being attached to the substrate and for their controlled release, (2) ensure the stability of the nanocarrier up to the point of delivery, and (3) clearance of the nanocarrier after the delivery. It is therefore envisaged that tailoring of the physicochemical properties of nanocarriers can greatly influence their reactivity and interaction in the biological milieu, and this is becoming an important parameter for increasing the efficacy of cancer therapy. This review emphasizes the importance of physicochemical properties of nanocarriers, and how they influence its usage as chemotherapeutic drug carriers. The goal of this review is to present a correlation between the physicochemical properties of the nanocarriers and its intended action, and how their design based on these properties can enhance their cancer combating abilities while minimizing damage to the healthy tissues. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 2906-2928, 2017.
Keywords: nanocarriers; nanomaterials; nanomedicine; physicochemical properties; theranostics.
© 2017 Wiley Periodicals, Inc.
Similar articles
-
Spatial-temporal event adaptive characteristics of nanocarrier drug delivery in cancer therapy.J Control Release. 2013 Nov 28;172(1):281-291. doi: 10.1016/j.jconrel.2013.08.022. Epub 2013 Sep 1. J Control Release. 2013. PMID: 24004884 Review.
-
Graphene as multifunctional delivery platform in cancer therapy.J Biomed Mater Res A. 2017 Aug;105(8):2355-2367. doi: 10.1002/jbm.a.36080. Epub 2017 Jun 19. J Biomed Mater Res A. 2017. PMID: 28371194 Review.
-
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.J Nanobiotechnology. 2016 May 26;14(1):39. doi: 10.1186/s12951-016-0193-x. J Nanobiotechnology. 2016. PMID: 27229857 Free PMC article. Review.
-
Programmable nanomedicine: synergistic and sequential drug delivery systems.Nanoscale. 2015 Feb 28;7(8):3381-91. doi: 10.1039/c4nr07677j. Nanoscale. 2015. PMID: 25631684 Review.
-
Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.Int J Nanomedicine. 2020 Mar 3;15:1437-1456. doi: 10.2147/IJN.S236927. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32184597 Free PMC article. Review.
Cited by
-
Nanocarriers as a Tool for the Treatment of Colorectal Cancer.Pharmaceutics. 2021 Aug 23;13(8):1321. doi: 10.3390/pharmaceutics13081321. Pharmaceutics. 2021. PMID: 34452282 Free PMC article. Review.
-
Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs.Front Neurosci. 2020 Jun 9;14:494. doi: 10.3389/fnins.2020.00494. eCollection 2020. Front Neurosci. 2020. PMID: 32581676 Free PMC article. Review.
-
Functional Peptide Nanofibers with Unique Tumor Targeting and Enzyme-Induced Local Retention Properties.Adv Funct Mater. 2018 Oct 31;28(44):1803969. doi: 10.1002/adfm.201803969. Epub 2018 Sep 14. Adv Funct Mater. 2018. PMID: 30505260 Free PMC article.
-
PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy.Appl Mater Today. 2018 Sep;12:177-190. doi: 10.1016/j.apmt.2018.05.002. Epub 2018 May 29. Appl Mater Today. 2018. PMID: 30511014 Free PMC article.
-
Insights on Quercetin Therapeutic Potential for Neurodegenerative Diseases and its Nano-technological Perspectives.Curr Pharm Biotechnol. 2024;25(9):1132-1141. doi: 10.2174/1389201025666230830125410. Curr Pharm Biotechnol. 2024. PMID: 37649295 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources